syndrome. We set out to identify and critically appraise the most commonly used Patient Information Leaflets (PILs) about Tourette syndrome worldwide. Method A computerised search was carried out using the web search engine Google, which ranks web pages by relevance using the PageRank algorithm. The search terms "Tourette*" AND "leaflet" OR "fact sheet" OR "information sheet" were used to identify PILs developed by a named source in English language with the purpose to provide an overview of Tourette syndrome. The contents of the PILs were subsequently screened for inclusion of the eight key facts identified by Tourettes Action-UK as the gold standard of essential information about Tourette syndrome to be communicated to patients. Each PIL was given a quality score from 0 to 1 for each key fact (total score 0-8): 0 points if the fact was not addressed, 0.5 points if the fact was partially addressed, and 1 point if the fact was fully addressed. Results A total of 18 PILs were identified, with quality scores ranging from 4 to 6.5. There were considerable discrepancies in the amount and accuracy of information provided by each PIL. The key facts about the range of severity of Tourette syndrome and the presence of co-morbidities such as ADHD and OCD were adequately covered by all PILs. Key information about the definition of Tourette syndrome and the existence of dedicated charities/support groups was present in 14/18 PILs. (78%) The majority of PILs (13/18; 72%) clearly stated that involuntary swearing as a tic (coprolalia) is present only in a subset of patients with Tourette syndrome. Four PILs (22%) mentioned pharmacological options outside neuroleptics, such as clonidine, and only one PIL (6%) covered behavioural, pharmacological and surgical treatment options. Finally, the recommendation of referring patients with Tourette syndrome to a specialist in neuropsychiatry was not explicitly mentioned in any of the PILs. Conclusions There is a wide selection of PILs available on Tourette syndrome, however the information provided in these PILs vary considerably in quality and comprehensiveness. Inclusion of key facts on Tourette syndrome would improve the delivery of care for this clinical population by ensuring that patients have access to more accurate, consistent and useful information. Objective Neuropsychological studies have highlighted the presence of specific cognitive deficits in two neurodevelopmental disorders affecting more commonly male children and often presenting in co-morbidity, Tourette syndrome (TS) and attention-deficit and hyperactivity disorder (ADHD). It is estimated that over 60% of children with TS present with co-morbid ADHD and the assessment of the relative contribution of tic symptoms and ADHD symptoms to cognitive problems in this patient population poses considerable challenges. We set out to determine the impact of co-morbid ADHD on cognitive function in male children with TS by conducting a controlled study with a comprehensive battery of neuropsychological tests.
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Method Participants included four groups of unmedicated ageand gender-matched children (mean age 10-12 years, range 6-15 years; 85%-100% male gender): TS group (n=13 children with a diagnosis of uncomplicated or 'pure' TS), TS+ADHD group n=8 children with TS and co-morbid ADHD), ADHD group (39 children with ADHD in the absence of tics) and controls n=66 healthy children). All patients had a DSM-validated diagnosis and were recruited from the Child Neuropsychiatry Unit, Varese, Italy, whereas healthy controls were randomly selected from a pool of research volunteers from local schools. Background/Aims Mazindol is known as one of the anorexiants for morbid obesity. According to previous study, the pharmacological property is similar to amphetamine, and this drug has an augmenting role of dopamine and serotonin by the inhibition of presynapse transporter. However, the neural basis of how mazindol acts on affective processing has been unclear. We investigated the cerebral response to nonverbal affective vocalisation to clarify the effect of mazindol by functional magnetic resonance imaging (fMRI). Methods 20 healthy subjects (11 males, 9 females: mean age: 28.2 years, SD=6.4) participated in this study. The study protocol was approved by the ethics committee of Nippon Medical School, and all subjects provided their informed consent. This experiment was performed by randomised controlled trial.
Each subject underwent two fMRI experiments, taking either a placebo or 0.5 mg of mazindol 2 hours before the scan. For each subject, the two experiments were separated by at least 2 weeks. Event-related fMRI experiments were performed in 
